Shares of ConvaTec Group PLC (LON:CTEC) have earned a consensus rating of “Hold” from the ten analysts that are currently covering the stock, Marketbeat Ratings reports. Two research analysts have rated the stock with a sell rating, six have issued a hold rating and two have given a buy rating to the company. The average twelve-month target price among brokerages that have issued ratings on the stock in the last year is GBX 245.78 ($3.31).

Several equities research analysts have issued reports on the stock. Peel Hunt lowered shares of ConvaTec Group to a “hold” rating and lowered their price target for the company from GBX 390 ($5.25) to GBX 250 ($3.36) in a report on Tuesday, October 17th. Citigroup reaffirmed a “neutral” rating and issued a GBX 290 ($3.90) target price on shares of ConvaTec Group in a report on Wednesday, October 11th. Deutsche Bank reaffirmed a “sell” rating and issued a GBX 180 ($2.42) target price on shares of ConvaTec Group in a report on Friday, December 1st. J P Morgan Chase & Co reaffirmed an “overweight” rating and issued a GBX 303 ($4.08) target price on shares of ConvaTec Group in a report on Wednesday, September 20th. Finally, Goldman Sachs Group reaffirmed a “buy” rating and issued a GBX 330 ($4.44) target price on shares of ConvaTec Group in a report on Monday, September 11th.

In related news, insider Ros Rivaz purchased 4,821 shares of ConvaTec Group stock in a transaction that occurred on Wednesday, December 6th. The shares were acquired at an average price of GBX 206 ($2.77) per share, for a total transaction of £9,931.26 ($13,366.43). Also, insider Christopher Gent purchased 38,889 shares of ConvaTec Group stock in a transaction that occurred on Wednesday, October 18th. The shares were bought at an average price of GBX 213 ($2.87) per share, for a total transaction of £82,833.57 ($111,485.29). In the last ninety days, insiders bought 98,618 shares of company stock worth $20,067,899.

Shares of ConvaTec Group (CTEC) opened at GBX 205.80 ($2.77) on Friday. ConvaTec Group has a fifty-two week low of GBX 181.40 ($2.44) and a fifty-two week high of GBX 349.10 ($4.70).

COPYRIGHT VIOLATION WARNING: This news story was reported by Daily Political and is the sole property of of Daily Political. If you are accessing this news story on another domain, it was illegally stolen and republished in violation of international copyright laws. The legal version of this news story can be read at https://www.dailypolitical.com/2017/12/15/convatec-group-plc-ctec-given-consensus-recommendation-of-hold-by-analysts.html.

About ConvaTec Group

ConvaTec Group Plc is a medical product and technology company. The Company focuses on therapies for the management of chronic conditions, including products used for advanced chronic and acute wound care, ostomy care, continence and critical care and infusion devices used in the treatment of diabetes and other conditions.

Analyst Recommendations for ConvaTec Group (LON:CTEC)

Receive News & Ratings for ConvaTec Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ConvaTec Group and related companies with MarketBeat.com's FREE daily email newsletter.